Greene, Chris http://orcid.org/0000-0003-4192-9433
Hanley, Nicole http://orcid.org/0000-0003-1451-3803
Reschke, Cristina R. http://orcid.org/0000-0002-0578-548X
Reddy, Avril
Mäe, Maarja A. http://orcid.org/0000-0001-6985-4379
Connolly, Ruairi
Behan, Claire
O’Keeffe, Eoin
Bolger, Isobel
Hudson, Natalie
Delaney, Conor http://orcid.org/0000-0001-8735-2225
Farrell, Michael A.
O’Brien, Donncha F.
Cryan, Jane
Brett, Francesca M.
Beausang, Alan
Betsholtz, Christer
Henshall, David C.
Doherty, Colin P.
Campbell, Matthew http://orcid.org/0000-0003-3325-240X
Funding for this research was provided by:
Science Foundation Ireland (16/RC/3948)
Article History
Received: 21 June 2021
Accepted: 22 March 2022
First Online: 14 April 2022
Competing interests
: Trinity College Dublin owns an intellectual property portfolio related to the regulation of claudin-5 to treat epilepsy. M.C., C.G., N.H. and C.D. are named inventors. All other authors declare no competing interest.